Amber Bio raises $26m to advance first-of-its-kind RNA editing platform

Amber Bio, a trailblazing biotechnology company, has launched with an oversubscribed $26 million seed financing round to pioneer multi-kilobase gene editing platforms. This innovative approach ... Read More